Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

VIP Play (VIPZ) Asset Writedowns and Impairment (2022 - 2024)

VIP Play's Asset Writedowns and Impairment history spans 3 years, with the latest figure at $5.9 million for Q4 2024.

  • For Q4 2024, Asset Writedowns and Impairment rose 26886.66% year-over-year to $5.9 million; the TTM value through Jun 2025 reached $5.9 million, up 26786.66%, while the annual FY2025 figure was $5.9 million, 26888.12% up from the prior year.
  • Asset Writedowns and Impairment reached $5.9 million in Q4 2024 per VIPZ's latest filing, up from -$4741.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $5.9 million in Q4 2024 to a low of -$17155.0 in Q1 2024.
  • Average Asset Writedowns and Impairment over 3 years is $854204.1, with a median of $21896.0 recorded in 2023.
  • Peak YoY movement for Asset Writedowns and Impairment: crashed 64.79% in 2023, then surged 26886.66% in 2024.
  • A 3-year view of Asset Writedowns and Impairment shows it stood at -$13647.0 in 2022, then soared by 260.45% to $21896.0 in 2023, then soared by 26886.66% to $5.9 million in 2024.
  • Per Business Quant, the three most recent readings for VIPZ's Asset Writedowns and Impairment are $5.9 million (Q4 2024), -$4741.0 (Q2 2024), and -$17155.0 (Q1 2024).